MENTALHEALTH.INFOLABMED.COM - A rare, brain-liquifying fungus, known scientifically as Cladophialophora bantiana, is showing a concerning increase in cases across the United States, prompting alarm from public health officials. While typically found worldwide in soil and decaying organic matter, recent data indicates a dramatic surge in infections, baffling scientists who are still seeking to understand the underlying causes and transmission pathways.
The Centers for Disease Control and Prevention (CDC) has highlighted a startling four-fold increase in identified cases within a mere two-year period.
This surge is particularly troubling as there is currently no federal system in place for tracking or surveilling this aggressive infection.
Experts admit they are largely in the dark regarding how the fungus spreads and, crucially, why its incidence is on a steady upward trend.
Understanding the Threat: A Fungal Menace
Cladophialophora bantiana is characterized as a dark or black mold. Its infection mechanism in humans remains poorly understood, according to the CDC. However, it is presumed to enter the body through inhalation or by contaminating an open wound. Once inside, the fungus often targets the brain, where it can lead to the formation of abscesses—collections of dead tissue and pus. This can result in severe neurological complications, including vision impairment and memory loss, as the brain swells under the fungal assault.
Case Numbers and Geographic Spread
Between January 2009 and July 2026, researchers documented 48 confirmed and one probable case of C. bantiana infections in the U.S. While yearly case counts between 2009 and 2023 typically ranged from one to five, a significant jump occurred with eight cases reported in 2024 and a further increase to 14 cases in 2025. The vast majority of these infections, 88%, were identified from brain samples, with 12% originating from lung samples. These cases have been reported across 21 U.S. states and the District of Columbia, with California (six cases), Florida (five), and Texas (five) reporting the highest numbers.
Laboratory Observations Signal Growing Concern
Data from the University of Washington underscores this alarming trend. Between 2017 and 2023, an average of 8.4 cases of C. bantiana were detected per 1,000 central nervous system (CNS) specimens submitted for fungal analysis. By 2025, this number had escalated dramatically, rising by 210% to 26 cases per 1,000 specimens. Joshua Lieberman, lead author of a relevant study, informed MedPage Today that at least one other fungal laboratory has observed a similar increase in this deadly mold. "We think that we’re probably undersampling," Lieberman stated, suggesting that the recorded numbers might represent an underestimate of the true incidence.
Beyond High-Risk Groups: A Wider Threat
Traditionally, individuals with compromised immune systems are considered most vulnerable to opportunistic fungal infections like those caused by black molds. However, the data for C. bantiana challenges this assumption. Approximately half of those infected were not immunocompromised, indicating that the fungus is not discriminating based on immune status. "People who have apparently healthy immune systems get the infection and are also at high risk of death," Lieberman observed. "It’s alarming that it occurs outside of those typical high-risk populations who have pretty profound immunosuppression."
Treatment Challenges and Grim Outcomes
The difficulty in treating C. bantiana infections adds another layer of concern. By the time symptoms become apparent and lead to medical attention, the condition can be misdiagnosed, often as a brain tumor. Even when correctly identified as a fungal infection, aggressive treatment protocols, which can include surgery and potent anti-fungal medications, do not guarantee a positive outcome. In one documented instance, a 44-year-old individual received what was described as "optimal treatment," yet succumbed to the infection within three months.
Unanswered Questions and Potential Environmental Links
While the CDC acknowledges the increase but states that "reasons for the apparent increase are unknown," Lieberman suggests a potential contributing factor: a warming planet. Researchers have been voicing concerns that rising global temperatures create a more hospitable environment for fungal pathogens, enabling them to thrive and adapt to previously inhospitable regions. Furthermore, an increase in natural disasters could potentially lead to more widespread fungal outbreaks. Historically, C. bantiana was considered a tropical infection linked to warmer climates and high humidity. However, its current acknowledgment as a worldwide pathogen, coupled with a similar jump in cases observed in France during 2022—the warmest year on record since 1900—lends credence to the environmental hypothesis.
The rise of this formidable fungus presents a significant public health challenge.
The lack of understanding regarding its transmission and the reasons behind its increased prevalence, combined with the severe outcomes and treatment difficulties, necessitates urgent scientific investigation and public health vigilance.
